- $949.53m
- $802.36m
- $209.47m
- 58
- 16
- 55
- 38
Annual income statement for Couchbase, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 103 | 124 | 155 | 180 | 209 |
| Cost of Revenue | |||||
| Gross Profit | 91.7 | 109 | 135 | 158 | 185 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 136 | 180 | 224 | 265 | 288 |
| Operating Profit | -33.1 | -56.3 | -69.3 | -84.5 | -78.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -38.9 | -57.2 | -67.5 | -78.8 | -72.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -40 | -58.2 | -68.5 | -80.2 | -74.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -40 | -58.2 | -68.5 | -80.2 | -74.7 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -44.1 | -61.1 | -68.5 | -80.2 | -74.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.06 | -1.39 | -1.51 | -1.63 | -1.45 |
| Dividends per Share |